About Glaucoma 

glaucoma
%D7%A8%D7%A7%D7%A2-01_edited.jpg

CorNeat eShunt Advantages 

Everlasting 

The outlet of the eShunt is placed in the intra-conal space, a space with minimal fibrotic potential

-

Scarring is the major cause of failure of any surgical approach to glaucoma and until the arrival of the eShunt no attempt has been made to drain the excess fluid to this deep orbital space

Bio-Integrating 

Covered with a synthetic, non-degradable, ECM-like material that stimulates cellular growth - integrating the tube into the subconjunctival space

-

Eliminates the need for using a tissue patch

-

Shortens the procedure and secures the device to the eye wall permanently  

Ease of Implantation 

Implantation procedure can be completed in under 15 minutes

-

Does not require additional, processed, tissue

-

Will probably not require an introducer or a dedicated tool

Physiological Approach

Engineered to imitate our own, physiologic, drainage pathways

-

Reacts to the changes in intraocular pressure and drains only the amount needed

CorNeat eShunt 

The CorNeat eShunt is determined to revolutionize the treatment of glaucoma. It is designed to regulate the intraocular pressure and addresses the shortcomings of existing solutions. Using advanced materials, the eShunt inlet, which is placed in the anterior chamber angle, mimics the trabecular meshwork’s function in terms of flow resistance. The eShunt outlet is uniquely positioned in the intraconal space, an area that does not scar and clog and can absorb the drained aqueous humor. The eShunt tube, which is covered by a synthetic ECM layer, seamlessly integrates with the ocular tissue as it traverses the subconjunctival space. 

Eye contact6.jpg
Eye contact3.jpg

Features

%D7%A8%D7%A7%D7%A2-01_edited.jpg

Regulatory Path 

Q&A

%D7%A8%D7%A7%D7%A2-01_edited.jpg

info@corneat.com

Visit us at
4 HaSheizaf St.

Ra'anana, Israel

Join Our Mailing List